Moneycontrol PRO
LAMF
LAMF
Jump to
  • Laurus Labs: Is it time to book profit?

    The company has a CDMO pipeline of 90+ human health projects, wherein 15 products are commercialised, targeting APIs and intermediates

  • Laurus Labs shares surge 8% as Trump govt resumes funding for AIDS programme

    The Trump administration on January 24 halted disbursement of funds to programmes to treat HIV, malaria and other diseases in developing countries for at least 90 days.

  • Laurus Labs: Operating leverage playing out

    In the coming quarters, performance in the areas of animal health, followed by formulations and crop science chemicals, can aid operating leverage

  • Dr Reddy’s enters pact with Gilead Sciences to manufacture, sell HIV drug Lenacapavir in India and 120 countries

    Lenacapavir is a USFDA approved drug used for treatment of human immunodeficiency virus type 1 (HIV-1) infection

  • HIV misconceptions: Does it always mean AIDS? Is it a death sentence?

    Myths and facts of HIV: It is primarily transmitted through unprotected sexual contact, sharing needles, and from mother to child during childbirth or breastfeeding. Here are some common misconceptions related to HIV infection.

  • Symptoms of HIV: Watch out for fever, fatigue, skin rash, night sweats, more

    HIV (Human immunodeficiency virus) attacks the immune system, specifically targeting CD4 cells, which are a type of white blood cell crucial for fighting infections. Here are the symptoms, causes and treatment strategies for HIV.

  • Everything you know about Testicular Cancer: myths vs facts

    Testicular cancer is a type of cancer that develops in the testicles, the male reproductive glands located inside the scrotum. Primarily affects young men aged 15-40. Despite myths, Testicular trauma doesn't increase the risk as treatment options like chemotherapy and surgery boast high cure rates, over 95 percent.

  • World AIDS Day 2023: Theme, history, significance and measures to reduce the risk

    World AIDS Day 2023: India has about 2.47 million people living with HIV with approximately 66,000 new cases recorded last year.

  • Laurus Labs: Margins appear to have bottomed out

    What holds promise for the company is the success in novel technologies related to gene and cell therapy and precision fermentation.

  • SC directs IAF to pay Rs 1.5 crore to veteran who contracted HIV due to medical negligence during 'Operation Parakram'

    The top court passed the verdict on an appeal by the IAF veteran who challenged an order of the National Consumer Disputes Redressal Commission (NCDRC) rejecting his claim for compensation.

  • Laurus Labs: Is the worst priced in?

  • Lupin gets USFDA nod for generic drugs to treat HIV infection

  • World AIDS Day 2022: History, theme, significance

  • Laurus Labs Q2: What worked, what didn't?

  • Man tests positive for Monkeypox, Covid-19 and HIV after Spain trip

  • HIV patients protest over drug shortage; health ministry says adequate stocks available

  • Cipla, DNDi launch 4-in-1 antiretroviral treatment for children with HIV

  • Spotlight on dating apps for role in adding to HIV-AIDS burden in India

  • More than 17 lakh Indians contracted HIV due to unprotected sex: RTI

  • In Kolkata, a cafe run by HIV-positive staff is fighting societal stigma

  • First woman reported cured of HIV after stem cell transplant

  • Laurus Labs: Diversification away from ARVs on track

  • World AIDS Day 2021: From Freddie Mercury to Charlie Sheen, celebrities who battled HIV

  • GlaxoSmithKline to initiate human trials to find HIV cure

  • HIV 'significant' risk factor for severe COVID: WHO

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347